BlackRock Science (BSTZ) Fundamental Analysis: Revenue, Earnings & Valuation

1.93 / 10

Underperform

BSTZ's fundamentals are a major concern, scoring only 1.9/10. Key issues include a negative rate of return on total assets (-10.08%) and a deeply negative annualized return (-20.16%), both in the lowest performance group. Earnings per share are declining YoY, and liquidity ratios are average. Only the fixed assets turnover ratio is high, but it is not enough to offset other weaknesses, leading to an overall underperform rating.

Analysis Checks(1/7)

Current liabilities / Total liabilities (%)

Value52.15

Score1/3

Weight14.68%

1M Return1.49%

Basic earnings per share (YoY growth rate %)

Value-80.91

Score0/3

Weight5.45%

1M Return0.58%

Rate of return on total assets (%)

Value-10.08

Score1/3

Weight13.43%

1M Return1.42%

Fixed assets turnover ratio

Value1031.01

Score3/3

Weight26.69%

1M Return2.65%

Annualized return on total assets (%)

Value-20.16

Score1/3

Weight13.43%

1M Return1.42%

Diluted earnings per share (YoY growth rate %)

Value-14.08

Score1/3

Weight11.99%

1M Return1.22%

Current assets / Total assets (%)

Value47.90

Score1/3

Weight14.32%

1M Return1.44%

Is BSTZ fundamentally strong?

BSTZ scores 1.93/10 on fundamentals and holds a Premium valuation at present. Backed by its 1.74% ROE, 3438.74% net margin, 10.77 P/E ratio, 1.01 P/B ratio, and -27.15% earnings growth, these metrics solidify its Underperform investment rating.